SID 2026Abstract 0530
Once-daily roflumilast cream or foam 0.3% for psoriasis
Subgroup analysis by skin type (DERMIS-1/2 and ARRECTOR)
Armstrong A, Lebwohl MG, Bhutani T, Gold LFS, Sobell JM, Cobos GA, Bukhalo M, Bhatia ND, Krupa D, Seal MS, Hanna D, Burnett P
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Psoriasis
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.561 · Not in PubMed: details from Crossref